Annual Activities Report 2011 - INCT-Inofar - UFRJ

Annual Report 2011 | INCT-INOFAR
75
II 2011 Evaluation and Follow-Up Meeting
On November 17 and 18, INCT-INOFAR had its II 2011 Evaluation and Follow-
Up Meeting at the Merlin Hotel in Copacabana, Rio de Janeiro. Researchers took turns
presenting the Institute’s research subprojects in radical innovation that are the most
advanced. Among them, pharmaceutical candidates for the recovery of myocardial
infarction, new antipsychotic prototypes, substances for the treatment of neuropathic pain,
leishmaniasis and Trypanosoma cruzi antiparasitic drugs, antiasthmatics, and vasodilators
for arterial and pulmonary hypertension.
In the field of incremental innovation, two projects that successfully achieved new synthetic
routes for generic drugs were presented. On this occasion, the trajectories followed to develop
a new synthetic route for atorvastatin, the active principle of the cholesterol reducing drug
Lipitor®, and of Sunitinib, the active principle in the chemotherapeutic drug Sutent®.
For this second meeting, the INCT-INOFAR Managing and Follow-Up Committee
(CGA) brought Mercedes Gonzalez and Hugo Cerecetto, Uruguayan experts in Medicinal
Chemistry and professors at the Universidad de la Republica (Udelar) in Montevideo. To
further enhance the team of external consultants employed by the Institute, the event also
had the presence of Andre Tempone, researcher from the Adolfo Lutz Institute, and of
Professor Paulo Ribeiro Costa, from the Natural Products Research Nucleus of UFRJ.
Around 40 INCT-INOFAR researchers
were present at the II 2011 Evaluation
and Follow-Up Meeting.